WeGene

Q: What does WeGene do?

解读基因的秘密, 遇见未来的自己

WeGene

解读基因的秘密, 遇见未来的自己

Founded 2014 China

China 12 employees Series B Total: $43.00M Biotechnology, Data Analytics +1

WeGene is a pioneering Chinese consumer-facing genetic testing company, established in 2014. With the slogan "解读基因的秘密, 遇见未来的自己," the company has garnered significant attention in the biotechnology and healthcare industries. WeGene has secured notable CNY20.00M Series B investment on 29 January 2018 from a consortium of investors including Puhua Capital, Zhuojia Huizhi Chuangtou, Fengji Touzi, Bioclub, Lanse Caihong Keji, Huada Yixue, and Hangzhou Fuzhuo Investment Management. Being the genetic testing company with the highest user base in China, WeGene offers a range of products including ancestry analysis, personalized exercise and weight management recommendations, nutritional genomics, and genomic medicine. The company has also engaged in research collaborations with prominent domestic and international institutions such as Shanghai Jiao Tong University, Hong Kong University of Science and Technology, Renmin University of China, Xiamen University, and the Chinese Academy of Sciences. WeGene's focus on using scientific methods to help consumers understand and utilize their genetic data reflects a commitment to driving meaningful utilization of genetic information. By leveraging the understanding and collaborative research on genetic data, the company aims to facilitate disease research and contribute to the development of new drugs. With a prevailing belief in data-driven decision-making and scientific methodologies, WeGene is dedicated to advancing the utilization of genetic data for the betterment of human health.

Funding Stage	Amount	Investors	Lead Investors	Date
Series B	CNY20.00M	7	Puhua Capital, Zhuojia Huizhi Chuangtou +5	29 Jan 2018
Series A	CNY20.00M	2	K2 Jijin, Fengji Touzi	01 Sep 2015
Angel Round	CNY3.00M	-		25 Sep 2014

Funding Stage

Amount

Investors

Lead Investors

Date

Series B

CNY20.00M

Puhua Capital, Zhuojia Huizhi Chuangtou +5

29 Jan 2018

Series A

CNY20.00M

K2 Jijin, Fengji Touzi

01 Sep 2015

Angel Round

CNY3.00M

25 Sep 2014

FAQ About WeGene

解读基因的秘密, 遇见未来的自己

WeGene was founded in 2014.

WeGene is headquartered in China.

WeGene operates in Biotechnology, Data Analytics and Health Care. Its work centres on Genetic Testing, Consumer Genetics, Personalized Medicine and Research Collaboration.

WeGene has approximately 12 employees.

WeGene has completed 3 funding rounds, raising a total of $43.00M. The latest funding stage is Series B.

Top alternatives and competitors to WeGene include Xcode Life Sciences, Sano Genetics, NalaGenetics, Lobo Genetics, Genoplan . These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

WeGene and Xcode Life Sciences are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About WeGene

Funding Rounds & Investors (3)

WeGene Alternatives & Competitors

FAQ About WeGene